{"id":"pranlukast-hydrate","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Headache"},{"rate":"5-10%","effect":"Nausea"},{"rate":"5-10%","effect":"Diarrhea"}]},"_chembl":{"chemblId":"CHEMBL1085767","moleculeType":"Small molecule","molecularWeight":"481.51"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Leukotrienes are pro-inflammatory mediators that play a key role in the pathogenesis of asthma and other inflammatory diseases. By blocking the action of leukotrienes, pranlukast hydrate reduces inflammation and improves symptoms in patients with asthma.","oneSentence":"Pranlukast hydrate is a leukotriene receptor antagonist that inhibits the action of leukotrienes, which are involved in the inflammatory process.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:51:48.852Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Asthma"}]},"trialDetails":[{"nctId":"NCT03826485","phase":"PHASE1","title":"Safety, Pharmacokinetic Study of PRIC in Healthy Adult Subjects","status":"UNKNOWN","sponsor":"SamA Pharmaceutical Co., Ltd","startDate":"2019-04-01","conditions":"Healthy","enrollment":48},{"nctId":"NCT00410735","phase":"PHASE3","title":"Study of ONO-1078 in Patients With Chronic Sinusitis","status":"COMPLETED","sponsor":"Ono Pharmaceutical Co. Ltd","startDate":"2006-12","conditions":"Chronic Sinusitis","enrollment":495}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":21,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Pranlukast hydrate","genericName":"Pranlukast hydrate","companyName":"SamA Pharmaceutical Co., Ltd","companyId":"sama-pharmaceutical-co-ltd","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Pranlukast hydrate is a leukotriene receptor antagonist that inhibits the action of leukotrienes, which are involved in the inflammatory process. Used for Asthma.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}